ArticleScientific reports2025
Antimicrobial activity of silver free powder coatings based on biocomponents.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, silver-free, low-temperature-curing epoxy powder coatings with antimicrobial functionality were developed. The cationic biopolymer ε-polylysine (PLY) in its protonated form, as well as its intercalation and co-intercalation products with aminododecanoic acid (ADA) in montmorillonite (MMT), were employed as environmentally friendly bioactive additives. The powder coatings were formulated using epoxy resin and a highly reactive phenolic curing agent and subsequently applied onto steel substrates. The resulting materials were comprehensively characterized in terms of surface morphology, gloss, hardness, adhesion, and wettability. The coating showed a water contact angle of approximately 85°and an antibacterial reduction exceeding 99% against E. coli and S. aureus under laboratory conditions (ISO 22196). Antimicrobial activity is most likely associated with electrostatic interaction between the cationic PLY and bacterial membranes. Overall, this study suggests a promising and sustainable, silver-free strategy for developing antimicrobial powder coatings that may be suitable for hygiene sensitive environments, pending further long-term and safety evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.